Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis

被引:28
|
作者
Pearson, Meredith M. [1 ]
Kim, Nicole J. [1 ]
Berry, Kristin [2 ]
Moon, Andrew M. [3 ]
Su, Feng [1 ]
Vutien, Philip [1 ]
Green, Pamela K. [2 ]
Williams, Emily C. [2 ,4 ]
Ioannou, George N. [1 ,5 ]
机构
[1] Univ Washington, Div Gastroenterol & Hepatol, Seattle, WA 98195 USA
[2] Vet Affairs Puget Sound Hlth Care Syst, Hlth Serv Res & Dev, Seattle, WA USA
[3] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
[4] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA
[5] Vet Affairs Puget Sound Hlth Care Syst, Div Gastroenterol, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; VIRUS-INFECTION; USE DISORDER; CONSUMPTION; PROGRESSION; PREDICTION; MORTALITY; DISEASE;
D O I
10.1002/hep4.1776
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Alcohol use can cause hepatic necroinflammation and worsening portal hypertension in patients with cirrhosis. We aimed to evaluate the associations between degree of alcohol use and clinical liver-related outcomes according to etiology of cirrhosis. In this retrospective cohort analysis, 44,349 U.S. veterans with cirrhosis from alcohol-associated liver disease (ALD), chronic hepatitis C virus (HCV) infection, or nonalcoholic fatty liver disease were identified who completed the Alcohol Use Disorders Identification Test Consumption questionnaire in 2012. Based on this score, level of alcohol use was categorized as none, low level, or unhealthy. Multivariable Cox proportional hazards regression was used to assess for associations between alcohol use and mortality, cirrhosis decompensation (new ascites, encephalopathy, or variceal bleeding), and hepatocellular carcinoma (HCC). At baseline, 36.4% of patients endorsed alcohol use and 17.1% had unhealthy alcohol use. During a mean 4.9 years of follow-up, 25,806 (57.9%) patients died, 9,409 (21.4%) developed a new decompensation, and 4,733 (11.1%) developed HCC. In patients with ALD-cirrhosis and HCV-cirrhosis, unhealthy alcohol use, compared with no alcohol use, was associated with higher risks of mortality (adjusted hazard ratio [aHR] = 1.13, 95% confidence interval [CI] = 1.07-1.19 and aHR = 1.14, 95% CI = 1.08-1.20, respectively) and decompensation (aHR = 1.18, 95% CI = 1.07-1.30 and aHR = 1.08, 95% CI = 1.00-1.16, respectively). Alcohol use was not associated with HCC, regardless of cirrhosis etiology. Conclusion: Unhealthy alcohol use was common in patients with cirrhosis and was associated with higher risks of mortality and cirrhosis decompensation in patients with HCV-cirrhosis and ALD-cirrhosis. Therefore, health care providers should make every effort to help patients achieve abstinence. The lack of association between alcohol use and HCC merits further investigation.
引用
收藏
页码:2080 / 2095
页数:16
相关论文
共 50 条
  • [32] LIVER-RELATED OUTCOMES IN PREGNANT WOMEN WITH CIRRHOSIS: A POPULATION-BASED STUDY.
    Flemming, Jennifer A.
    Mullin, Monica
    Lu, Jacquie
    Velez, Maria
    Sarkar, Monika
    Brogly, Susan
    Terrault, Norah
    HEPATOLOGY, 2019, 70 : 40A - 41A
  • [33] Individual Differences in the Associations Between Risk Factors for Alcohol Use Disorder and Alcohol Use-Related Outcomes
    Haeny, Angela M.
    Gueorguieva, Ralitza
    Jackson, Asti
    Morean, Meghan E.
    Krishnan-Sarin, Suchitra
    DeMartini, Kelly S.
    Pearlson, Godfrey D.
    Anticevic, Alan
    Krystal, John H.
    O'Malley, Stephanie S.
    PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2021, 35 (05) : 501 - 513
  • [34] Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use
    Aberg, Fredrik
    Farkkila, Martti
    Salomaa, Veikko
    Jula, Antti
    Mannisto, Satu
    Perola, Markus
    Lundqvist, Annamari
    Mannisto, Ville
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [35] The Hidden Burden of Liver-Related Mortality in Patients with Cirrhosis and Low Meld Score
    Mazumder, Nikhilesh
    Atiemo, Kofi
    Daud, Amna
    Montag, Samantha
    Kho, Abel
    Abecassis, Michael M.
    Ladner, Daniela
    Levitsky, Josh
    HEPATOLOGY, 2018, 68 : 653A - 653A
  • [36] Hepatic recompensation according to Baveno VII criteria significantly reduces liver-related mortality in patients with decompensated alcohol-related cirrhosis
    Hofer, Benedikt
    Simbrunner, Benedikt
    Hartl, Lukas
    Jachs, Mathias
    Balcar, Lorenz
    Paternostro, Rafael
    Schwabl, Philipp
    Semmler, Georg
    Scheiner, Bernhard
    Staettermayer, Albert
    Trauner, Michael
    Mandorfer, Mattias
    Reiberger, Thomas
    JOURNAL OF HEPATOLOGY, 2022, 77 : S629 - S630
  • [37] Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use
    Fredrik Åberg
    Martti Färkkilä
    Veikko Salomaa
    Antti Jula
    Satu Männistö
    Markus Perola
    Annamari Lundqvist
    Ville Männistö
    Communications Medicine, 3
  • [38] ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis
    Calzadilla-Bertot, Luis
    Vilar-Gomez, Eduardo
    Wong, Vincent Wai-Sun
    Romero-Gomez, Manuel
    Aller-de la Fuente, Rocio
    Wong, Grace Lai-Hung
    Castellanos, Marlen
    Eslam, Mohammed
    Desai, Archita P.
    Jeffrey, Gary P.
    George, Jacob
    Chalasani, Naga
    Adams, Leon A.
    HEPATOLOGY, 2021, 73 (06) : 2238 - 2250
  • [39] The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease
    Lee, Hye Won
    Kim, Kun Hee
    Ahn, Sang Hoon
    Lee, Han Chu
    Choi, Jonggi
    LIVER INTERNATIONAL, 2024, 44 (06) : 1448 - 1455
  • [40] The Pattern of Alcohol Use in Alcohol-Related Cirrhosis in Indian Patients: AUDIT Indian Liver Study
    Sharma, Mithun
    Gora, Baqar A.
    Kulkarni, Anand
    Soumya, T. R.
    Shaik, Sameer
    Jagtap, Nitin
    Alla, Manasa
    Gupta, Rajesh
    Archana, Chintam
    Qadri, Sabreena
    Talukdar, Rupjyoti
    Rao, Padaki N.
    Reddy, Duvvur Nageshwar
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (03) : 437 - 446